And offering a fast-track to approve drugs the Trump administration views as a priority. Welcome to the new Food and Drug ...

All the figurative FDA trains are running on time, according to the agency’s leader Marty Makary, M.D. | “I'm proud to report ...

The Food and Drug Administration says it will begin offering faster reviews to new medicines that align with Trump ...

Food and Drug Administration Commissioner Marty Makary announced that the agency intends to fast-track reviews for certain ...

FDA Commissioner Dr Marty Makary tried to allay industry concerns about recent cuts and outlined his agenda for the future.

FDA Commissioner Marty Makary said that one of his key priorities is to modernize the agency by streamlining the drug review ...

Speaking at BIO 2025, Makary bemoaned what he called “unnecessary steps” and “avoidable delays” in the U.S. regulatory ...

Vinay Prasad is taking on several big roles at the FDA, solidifying his position as a top adviser to Commissioner Marty ...

The US Food and Drug Administration announced a new national priority voucher plan that aims to cut drug review times to one ...

The Food and Drug Administration announced the launch of a new program to fast-track agency approvals for drug manufacturers ...

According to an internal email, the agency may be in for more consolidation in areas including human resources, ...

US regulators, under the guidance of FDA Commissioner Marty Makary, are launching a program to accelerate drug approvals, ...